Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
1.960
-0.010 (-0.51%)
Nov 13, 2026, 4:00 PM EST - Market closed

PACB Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-131.23-546.38-309.85-306.74-314.25-181.22
Depreciation & Amortization
377.3386.4153.3526.5317.3211.59
Loss (Gain) From Sale of Assets
-48.1-----
Asset Writedown & Restructuring Costs
-359.315184.5---
Loss (Gain) From Sale of Investments
-1.03-4.37-13.04-12.84-0.244.01
Stock-Based Compensation
31.8541.6771.0472.1278.6173.36
Other Operating Activities
10.61-7.99-151.4720.719.32-39.24
Change in Accounts Receivable
-7.71-7.929.09-17.835.46-7.17
Change in Inventory
-22.12-1.42-8.32-13.84-33.91-13.11
Change in Accounts Payable
-5.372.481.410.211.036.36
Change in Unearned Revenue
1.120.1-2.11-10.42-3.7325.74
Change in Other Net Operating Assets
17.0311.2-40.65-17.07-22.818.5
Operating Cash Flow
-136.95-111.21-206.06-259.17-263.21-111.18
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-6.45-2.71-6.19-8.84-16.75-5.93
Sale of Property, Plant & Equipment
50-----
Cash Acquisitions
----0.1--319.79
Sale (Purchase) of Intangibles
-7.06-5---0.18-
Investment in Securities
98.47123.16130.1913.55133.01-352.81
Other Investing Activities
-1.9-----
Investing Cash Flow
133.07115.451244.6116.08-678.53

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-----895.54
Long-Term Debt Repaid
---50.69-1.84-1.61-0.36
Net Debt Issued (Repaid)
---50.69-1.84-1.61895.18
Issuance of Common Stock
3.153.437.7204.5211.23326.65
Other Financing Activities
----93.79--52.25
Financing Cash Flow
3.153.43-42.99108.899.621,170

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-0.737.67-125.04-145.68-137.51379.87

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-143.4-113.92-212.25-268.02-279.96-117.11
Free Cash Flow Growth
------
Free Cash Flow Margin
-88.85%-71.20%-137.81%-133.66%-218.20%-89.73%
Free Cash Flow Per Share
-0.47-0.38-0.77-1.06-1.25-0.57
Levered Free Cash Flow
44.0697.55-95.64-311.6746.5-24.54
Unlevered Free Cash Flow
48.84101.89-87.26-302.755.68-16.71

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
8.268.2614.8115.6914.056.93
Change in Working Capital
-17.044.44-40.58-58.96-53.9720.33
SEC Filings: 10-K · 10-Q